Figure 1. Some of the alterations in the metabolic risk profile that have been found to be related to abdominal obesity assessed by anthropometry and later to excess visceral adiposity/ectopic fat ...
Fat necrosis refers to dead or damaged breast tissue that often manifests as a noncancerous lump under the skin. In most cases, these lumps go away on their own and don’t return. Fat necrosis of ...
If you're trying to lose weight and blast belly fat, eating a healthy dose of fiber can help. Shrinking your waistline doesn't only feel good, but it's healthier to have a slimmer midsection. While ...
Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...
A doctor shared tips to help you minimise stress GETTY "High cortisol levels, in combination with high insulin levels, may be responsible. Other research suggests that ghrelin, a 'hunger hormone' may ...
JPMorgan upgraded Bluebird Bio (BLUE) to Neutral from Underweight without a price target after the company entered into a definitive agreement to be taken private. The firm expects a completed ...
In the race to develop satellite services, AT&T and Verizon are both hailing recent tests that show they can power video calls on US phones using next-gen satellites from AST SpaceMobile. The ...
As an ISSA-certified trainer, I've seen countless clients struggle with stubborn body fat. They came to me looking for effective ways to shed unwanted pounds and get healthier. Through the years, I've ...
Bluebird Bio (NASDAQ: BLUE) said its planned acquisition by two investment firms is, according to its board, “in the best interest of stockholders”—but enough of them felt otherwise on ...
Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. Bluebird on ...
A pair of investors will acquire bluebird bio in a deal worth only $29 million upfront after the gene therapy maker ran out of time … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback